Avidity Biosciences, Inc. (RNA)
NASDAQ: RNA · Real-Time Price · USD
69.83
+0.03 (0.04%)
At close: Nov 4, 2025, 4:00 PM EST
69.85
+0.02 (0.03%)
After-hours: Nov 4, 2025, 6:27 PM EST

Avidity Biosciences Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2024FY 2023FY 2022FY 2021FY 20202018 - 2019
Period Ending
Nov '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2018 - 2019
10,0313,4706711,4741,115958
Upgrade
Market Cap Growth
76.52%417.36%-54.52%32.27%16.40%-
Upgrade
Enterprise Value
8,8531,8891391,080703617
Upgrade
Last Close Price
69.8329.089.0522.1923.7725.52
Upgrade
PS Ratio
934.97318.3970.15159.85119.53141.10
Upgrade
PB Ratio
7.072.441.342.552.923.13
Upgrade
P/TBV Ratio
8.412.441.342.552.923.13
Upgrade
EV/Sales Ratio
825.18173.3114.50117.1175.3590.94
Upgrade
Debt / Equity Ratio
0.000.010.020.020.030.00
Upgrade
Asset Turnover
0.010.010.020.020.020.03
Upgrade
Quick Ratio
8.8215.617.4911.8413.7022.58
Upgrade
Current Ratio
9.2615.747.5812.0013.8622.74
Upgrade
Return on Equity (ROE)
-37.76%-33.47%-39.34%-36.27%-34.32%-23.62%
Upgrade
Return on Assets (ROA)
-24.01%-21.60%-23.24%-20.97%-19.38%-12.85%
Upgrade
Return on Capital (ROIC)
-26.87%-24.39%-26.79%-22.78%-21.07%-14.51%
Upgrade
Earnings Yield
-4.54%-9.29%-31.65%-11.80%-10.59%-4.63%
Upgrade
FCF Yield
-5.01%-8.88%-18.39%-9.43%-8.84%-3.99%
Upgrade
Buyback Yield / Dilution
-48.40%-52.83%-39.97%-25.91%-91.24%-698.49%
Upgrade
Updated Jun 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q